Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E6NW
|
||||
Former ID |
DNC003716
|
||||
Drug Name |
VER-5384
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527037] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H18N2O
|
||||
Canonical SMILES |
CC(CN1CCC2=C1C3=C(C=C2)OCC3)N
|
||||
InChI |
1S/C13H18N2O/c1-9(14)8-15-6-4-10-2-3-12-11(13(10)15)5-7-16-12/h2-3,9H,4-8,14H2,1H3/t9-/m0/s1
|
||||
InChIKey |
OBQZQQHWYDPMDY-VIFPVBQESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527037] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527037] | ||
5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527037] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.